An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects

被引:0
作者
Desmond Padhi
Craig B. Langman
Sahar Fathallah-Shaykh
Bradley A. Warady
Isidro B. Salusky
Edward Lee
Christine Wang
Edward Posvar
机构
[1] Amgen Inc.,Early Development
[2] Northwestern University,Feinberg School of Medicine, Children’s Memorial Hospital
[3] University of Alabama at Birmingham,Division of Pediatric Nephrology
[4] University of Missouri–Kansas City School of Medicine,Children’s Mercy Hospitals and Clinics
[5] David Geffen School of Medicine at UCLA,Division of Pediatric Nephrology, Department of Pediatrics
[6] Amgen Inc.,Metabolic Disorders
来源
Pediatric Nephrology | 2012年 / 27卷
关键词
Hyperparathyroidism; CKD–MBD; Hemodialysis; End-stage renal disease; Pharmacokinetics; Pharmacodynamics; Secondary;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1953 / 1959
页数:6
相关论文
共 137 条
  • [1] Block GA(2000)Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients Clin Nephrol 54 318-324
  • [2] Goodman WG(2001)Recent developments in the management of secondary hyperparathyroidism Kidney Int 59 1187-1201
  • [3] Delmez JA(1989)Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium J Clin Invest 83 1349-1355
  • [4] Tindira C(2011)Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism Kidney Int 79 112-119
  • [5] Grooms P(2004)Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 1516-1525
  • [6] Dusso A(2005)Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means Pediatr Nephrol 20 399-403
  • [7] Windus DW(2005)Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study J Am Soc Nephrol 16 800-807
  • [8] Slatopolsky E(2005)Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl Nephrol Dial Transplant 20 2186-2193
  • [9] Wesseling-Perry K(1998)Calcimimetics with potent and selective activity on the parathyroid calcium receptor Proc Natl Acad Sci USA 95 4040-4045
  • [10] Pereira RC(1993)Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid Nature 366 575-580